These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30892092)

  • 1. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
    Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro study of hydrochloric norvancomycin encapsulated poly (d,l-lactide-co-glycolide, PLGA) microspheres for potential use in osteomyelitis.
    Yang H; Hao Y; Liu Q; Mi Z; Wang Z; Zhu L; Feng Q; Hu N
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1326-1330. PubMed ID: 27776425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
    Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
    J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.
    Reinbold J; Hierlemann T; Urich L; Uhde AK; Müller I; Weindl T; Vogel U; Schlensak C; Wendel HP; Krajewski S
    Drug Des Devel Ther; 2017; 11():2753-2762. PubMed ID: 29075100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres.
    Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P
    J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro characterization of rifampicin-loaded porous poly (ε-caprolactone) microspheres for sustained skeletal delivery.
    Mei Q; Luo P; Zuo Y; Li J; Zou Q; Li Y; Jiang D; Wang Y
    Drug Des Devel Ther; 2018; 12():1533-1544. PubMed ID: 29910601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
    Gajendiran M; Divakar S; Raaman N; Balasubramanian S
    Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
    Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactic-
    Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and
    Reddy GA; Handa M; Garabadu D; Kumar R; Kushawaha PK; Shukla R
    Drug Dev Ind Pharm; 2023 Jan; 49(1):129-138. PubMed ID: 36852720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
    O'Hara P; Hickey AJ
    Pharm Res; 2000 Aug; 17(8):955-61. PubMed ID: 11028941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
    Xu W; Wei X; Wei K; Cao X; Zhong S
    Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Doolaanea AA
    Drug Deliv Transl Res; 2016 Jun; 6(3):308-18. PubMed ID: 26817478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
    Abulateefeh SR; Alkawareek MY; Alkilany AM
    Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups.
    Wang J; Helder L; Shao J; Jansen JA; Yang M; Yang F
    Int J Pharm; 2019 Jun; 564():1-9. PubMed ID: 30978487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
    Gilchrist SE; Rickard DL; Letchford K; Needham D; Burt HM
    Mol Pharm; 2012 May; 9(5):1489-501. PubMed ID: 22482935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.